{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:23:57Z","timestamp":1791260637056,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1038\/s41401-021-00793-3","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T09:02:49Z","timestamp":1639990969000},"page":"2139-2146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Natural product-based screening led to the discovery of a novel PXR agonist with anti-cholestasis activity"],"prefix":"10.1038","volume":"43","author":[{"given":"Dong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-yu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-long","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-chang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"793_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","volume":"339","author":"M Trauner","year":"1998","unstructured":"Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med. 1998;339:1217\u201327.","journal-title":"N Engl J Med"},{"key":"793_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/hep.27744","volume":"62","author":"NS Ghonem","year":"2015","unstructured":"Ghonem NS, Assis DN, Boyer JL. On fibrates and cholestasis: a review. Hepatology. 2015;62:635\u201343.","journal-title":"Hepatology."},{"key":"793_CR3","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","volume":"62","author":"U Beuers","year":"2015","unstructured":"Beuers U, Trauner M, Poupon R. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatol. 2015;62:S25\u201337.","journal-title":"J Hepatol"},{"key":"793_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375:631\u201343.","journal-title":"N Engl J Med"},{"key":"793_CR5","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/liv.13880","volume":"38","author":"J Goldstein","year":"2018","unstructured":"Goldstein J, Levy C. Novel and emerging therapies for cholestatic liver diseases. Liver Int. 2018;38:1520\u201335.","journal-title":"Liver Int"},{"key":"793_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ajg.2017.440","volume":"113","author":"MH Harms","year":"2018","unstructured":"Harms MH, Lammers WJ, Thorburn D, Corpechot C, Invernizzi P, Janssen H, et al. Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: risk factors and time trends in incidence and outcome. Am J Gastroenterol. 2018;113:254\u201364.","journal-title":"Am J Gastroenterol"},{"key":"793_CR7","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1126\/science.1060762","volume":"292","author":"RE Watkins","year":"2001","unstructured":"Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science. 2001;292:2329\u201333.","journal-title":"Science."},{"key":"793_CR8","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1073\/pnas.051551698","volume":"98","author":"JL Staudinger","year":"2001","unstructured":"Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA. 2001;98:3369\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"793_CR9","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.bcp.2012.01.030","volume":"83","author":"Y Chen","year":"2012","unstructured":"Chen Y, Tang Y, Guo C, Wang J, Boral D, Nie D. Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. Biochem Pharmacol. 2012;83:1112\u201326.","journal-title":"Biochem Pharmacol"},{"key":"793_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/dmd.112.048694","volume":"41","author":"HI Swanson","year":"2013","unstructured":"Swanson HI, Wada T, Xie W, Renga B, Zampella A, Distrutti E, et al. Role of nuclear receptors in lipid dysfunction and obesity-related diseases. Drug Metab Dispos. 2013;41:1\u201311.","journal-title":"Drug Metab Dispos"},{"key":"793_CR11","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1210\/me.2002-0421","volume":"17","author":"JM Rosenfeld","year":"2003","unstructured":"Rosenfeld JM, Vargas R Jr, Xie W, Evans RM. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol Endocrinol. 2003;17:1268\u201382.","journal-title":"Mol Endocrinol"},{"key":"793_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/87912","volume":"7","author":"TW Synold","year":"2001","unstructured":"Synold TW, Dussault I, Forman BM. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med. 2001;7:584\u201390.","journal-title":"Nat Med"},{"key":"793_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jsbmb.2011.06.012","volume":"130","author":"JW Jonker","year":"2012","unstructured":"Jonker JW, Liddle C, Downes M. FXR and PXR: Potential therapeutic targets in cholestasis. J Steroid Biochem. 2012;130:147\u201358.","journal-title":"J Steroid Biochem"},{"key":"793_CR14","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1073\/pnas.051014398","volume":"98","author":"W Xie","year":"2001","unstructured":"Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, et al. An essential role for nuclear receptors SXR\/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA. 2001;98:3375\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"793_CR15","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/liv.12603","volume":"35","author":"R van Dijk","year":"2015","unstructured":"van Dijk R, Kremer AE, Smit W, van den Elzen B, van Gulik T, Gouma D, et al. Characterization and treatment of persistent hepatocellular secretory failure. Liver Int. 2015;35:1478\u201388.","journal-title":"Liver Int"},{"key":"793_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jep.2015.01.047","volume":"164","author":"X Zhang","year":"2015","unstructured":"Zhang X, Ma Z, Liang Q, Tang X, Hu D, Liu C, et al. Tanshinone IIA exerts protective effects in a LCA-induced cholestatic liver model associated with participation of pregnane X receptor. J Ethnopharmacol. 2015;164:357\u201367.","journal-title":"J Ethnopharmacol"},{"key":"793_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bph.13729","volume":"174","author":"H Zeng","year":"2017","unstructured":"Zeng H, Jiang Y, Chen P, Fan X, Li D, Liu A, et al. Schisandrol B protects against cholestatic liver injury through pregnane X receptors. Br J Pharmacol. 2017;174:672\u201388.","journal-title":"Br J Pharmacol"},{"key":"793_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1021\/jm100968b","volume":"54","author":"C Festa","year":"2010","unstructured":"Festa C, De Marino S, D'Auria MV, Bifulco G, Renga B, Fiorucci S, et al. Solomonsterols A and B from Theonella swinhoei. the first example of C-24 and C-23 sulfated sterols from a marine source endowed with a PXR agonistic activity. J Med Chem. 2010;54:401\u20135.","journal-title":"J Med Chem"},{"key":"793_CR19","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1021\/acs.jmedchem.6b00605","volume":"59","author":"J Zhu","year":"2016","unstructured":"Zhu J, Wang R, Lou L, Li W, Tang G, Bu X, et al. Jatrophane diterpenoids as modulators of P-glycoprotein-dependent multidrug resistance (MDR): advances of structure-activity relationships and discovery of promising MDR reversal agents. J Med Chem. 2016;59:6353\u201369.","journal-title":"J Med Chem"},{"key":"793_CR20","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1021\/acs.orglett.0c01443","volume":"22","author":"W Li","year":"2020","unstructured":"Li W, Wang RM, Pan YH, Zhao YY, Yuan FY, Huang D, et al. Crotonpenoids A and B, two highly modified clerodane diterpenoids with a tricyclo [7.2.1.02,7] dodecane core from Croton yanhuii: isolation, structural elucidation, and biomimetic semisynthesis. Org Lett. 2020;22:4435\u20139.","journal-title":"Org Lett"},{"key":"793_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2021.03.030","volume":"509","author":"J Sang","year":"2021","unstructured":"Sang J, Li W, Diao HJ, Fan RZ, Huang JL, Gan L, et al. Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells. Cancer Lett. 2021;509:13\u201325.","journal-title":"Cancer Lett"},{"key":"793_CR22","doi-asserted-by":"publisher","first-page":"112103","DOI":"10.1016\/j.jep.2019.112103","volume":"245","author":"S Fan","year":"2019","unstructured":"Fan S, Liu C, Jiang Y, Gao Y, Chen Y, Fu K, et al. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice. J Ethnopharmacol. 2019;245:112103\u201312.","journal-title":"J Ethnopharmacol"},{"key":"793_CR23","doi-asserted-by":"publisher","first-page":"153520","DOI":"10.1016\/j.phymed.2021.153520","volume":"84","author":"YY Zhao","year":"2021","unstructured":"Zhao YY, Yao XP, Jiao TY, Tian JN, Gao Y, Fan SC, et al. Schisandrol B promotes liver enlargement via activation of PXR and YAP pathways in mice. Phytomedicine. 2021;84:153520\u20136.","journal-title":"Phytomedicine."},{"key":"793_CR24","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S0040-4039(01)96700-0","volume":"12","author":"P Narayanan","year":"1971","unstructured":"Narayanan P, R\u00f6hrl M, Zechmeister K, Engel DW, Hoppe W. Structure of 7-hydroxy-lathyrol a further diterpene from Euphorbia lathyris. Tetrahedron Lett. 1971;12:1325\u20138.","journal-title":"Tetrahedron Lett"},{"key":"793_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/hep.30131","volume":"69","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Feng D, Ma X, Fan S, Gao Y, Fu K, et al. Pregnane X receptor regulates liver size and liver cell fate by yes-associated protein activation in mice. Hepatology. 2019;69:343\u201358.","journal-title":"Hepatology"},{"key":"793_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2017.10.044","volume":"818","author":"X Li","year":"2019","unstructured":"Li X, Sun J, Fan X, Guan L, Li D, Zhou Y, et al. Schisandrol B promotes liver regeneration after partial hepatectomy in mice. Eur J Pharmacol. 2019;818:96\u2013102.","journal-title":"Eur J Pharmacol"},{"key":"793_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629\u201361.","journal-title":"J Nat Prod"},{"key":"793_CR28","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1021\/cr078350s","volume":"108","author":"Q-W Shi","year":"2008","unstructured":"Shi Q-W, Su X-H, Kiyota H. Chemical and pharmacological research of the plants in genus Euphorbia. Chem Rev. 2008;108:4295\u2013327.","journal-title":"Chem Rev"},{"key":"793_CR29","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1021\/cr400541j","volume":"114","author":"A Vasas","year":"2014","unstructured":"Vasas A, Hohmann J. Euphorbia diterpenes: isolation, structure, biological activity, and synthesis. Chem Rev. 2014;114:8579\u2013612.","journal-title":"Chem Rev"},{"key":"793_CR30","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1021\/acs.jmedchem.8b01693","volume":"62","author":"Q-Q Song","year":"2019","unstructured":"Song Q-Q, Rao Y, Tang GH, Sun ZH, Zhang JS, Huang ZS, et al. Tigliane diterpenoids as a new type of antiadipogenic agents inhibit GR\u03b1-dexras1 axis in adipocytes. J Med Chem. 2019;62:2060\u201375.","journal-title":"J Med Chem"},{"key":"793_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2310\/7750.2012.12050","volume":"17","author":"AK Gupta","year":"2013","unstructured":"Gupta AK, Paquet M. Ingenol mebutate: a promising treatment for actinic keratoses and nonmelanoma skin cancers. J Cutan Med Surg. 2013;17:173\u20139.","journal-title":"J Cutan Med Surg"},{"key":"793_CR32","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2174\/156802611796904924","volume":"11","author":"I Kissin","year":"2011","unstructured":"Kissin I, Szallasi A. Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studiesto clinical trials. Curr Top Med Chem. 2011;11:2159\u201370.","journal-title":"Curr Top Med Chem"},{"key":"793_CR33","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.2174\/1389557515666150511154108","volume":"15","author":"GA Miana","year":"2015","unstructured":"Miana GA, Riaz M, Shahzad-ul-Hussan S, Paracha RZ, Paracha UZ. Prostratin: an overview. Mini-Rev Med Chem. 2015;15:1122\u201330.","journal-title":"Mini-Rev Med Chem"},{"key":"793_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2018.02.002","volume":"824","author":"Y Kong","year":"2018","unstructured":"Kong Y, Gao X, Wang C, Ning C, Liu K, Liu Z, et al. Protective effects of yangonin from an edible botanical kava against lithocholic acid-induced cholestasis and hepatotoxicity. Eur J Pharmacol. 2018;824:64\u201371.","journal-title":"Eur J Pharmacol"},{"key":"793_CR35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/17425255.2018.1476488","volume":"14","author":"CD Buchman","year":"2018","unstructured":"Buchman CD, Chai SC, Chen T. A current structural perspective on PXR and CAR in drug metabolism. Expert Opin Drug Metab Toxicol. 2018;14:635\u201347.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"793_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s005350170150","volume":"36","author":"D-H Jeong","year":"2001","unstructured":"Jeong D-H, Jang JJ, Lee SJ, Lee JH, Lim IK, Lee MJ, et al. Expression patterns of cell cycle-related proteins in a rat cirrhotic model induced by CCl4 or thioacetamide. J Gastroenterol. 2001;36:24\u201332.","journal-title":"J Gastroenterol"},{"key":"793_CR37","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1124\/dmd.114.059394","volume":"42","author":"X Fan","year":"2014","unstructured":"Fan X, Chen P, Tan H, Zeng H, Jiang Y, Wang Y, et al. Dynamic and coordinated regulation of KEAP1-NRF2-ARE and p53\/p21 signaling pathways is associated with acetaminophen injury responsive liver regeneration. Drug Metab Dispos. 2014;42:1532\u20139.","journal-title":"Drug Metab Dispos"},{"key":"793_CR38","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1124\/dmd.114.059535","volume":"42","author":"X Fan","year":"2014","unstructured":"Fan X, Jiang Y, Wang Y, Tan H, Zeng H, Wang Y, et al. Wuzhi Tablet (Schisandra Sphenanthera extract) protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of NRF2-ARE and p53\/p21 pathways. Drug Metab Dispos. 2014;42:1982\u201390.","journal-title":"Drug Metab Dispos"},{"key":"793_CR39","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/hep.22129","volume":"47","author":"G Dai","year":"2008","unstructured":"Dai G, He L, Bu P, Wan YJ. Pregnane X receptor is essential for normal progression of liver regeneration. Hepatology. 2008;47:1277\u201387.","journal-title":"Hepatology"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00793-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00793-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00793-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T07:19:22Z","timestamp":1659338362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00793-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1038\/s41401-021-00793-3","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]},"assertion":[{"value":"1 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}